RhumbLine Advisers
PAVM icon

RhumbLine Advisers’s PAVmed PAVM Stock Holding History

RhumbLine Advisers’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-144
Closed -$85K – 3199
2022
Q1 		$85K Buy
144
+2
+1% +$1.49K ﹤0.01% 2919
2021
Q4 		$157K Sell
142
-4
-3% -$8.7K ﹤0.01% 2882
2021
Q3 		$562K Buy
146
+6
+4% +$18.9K ﹤0.01% 2492
2021
Q2 		$402K Buy
140
+72
+106% +$170K ﹤0.01% 2660
2021
Q1 		$137K Buy
68
+11
+19% +$16.5K ﹤0.01% 2901
2020
Q4 		$54K Buy
57
+6
+12% +$5.13K ﹤0.01% 3018
2020
Q3 		$40K Sell
51
-13
-20% -$11.6K ﹤0.01% 2959
2020
Q2 		$61K Buy
+64
New +$64K ﹤0.01% 3019

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers's PAVM Position: Q2 2022 in Review

RhumbLine Advisers sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 144 shares — an estimated $85K sold.

RhumbLine Advisers first reported a position in PAVM in Q2 2020 and held it in 8 quarters. The position peaked at $562K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • RhumbLine Advisers reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 144 PAVmed shares in Q2 2022, an estimated $85K.
  • RhumbLine Advisers first reported a position in PAVmed in Q2 2020 and held it in 8 quarters.
  • RhumbLine Advisers's PAVmed position peaked at $562K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.